Sino Biopharmaceutical | 1177 - Cost Of Sales


Sino Biopharmaceutical reported CNY3.08B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Jiangsu Hengrui CNY 1.09B 76.27M Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025